Naogen Pharma
  • Home
  • About Naogen Pharma
    • Our Management team
    • Our Scientific Advisers
    • Our history
  • Product
  • Imaging in nuclear cardiology
    • Detection of myocardial ischaemia
  • Recruitments
  • News
  • Contact
  • English
    • French

The Board of Director

Home The Board of Director
  • Jean-Pierre Cabocel

 

  • Philippe Cholet

 

  • Claude Cholet
Actualité du 08/03/2024

March 2024: Naogen Pharma will be present at the 10th JFMN in Biarritz

NAOGEN PHARMA will be present at the 10th JFMN – Journées Francophones de Médecine Nucléaire from 21st to 23rd of march in BIARRITZ. Meet us at booth N° 18.1 (Lemer…

Lire l'actualité
Actualité du 29/01/2024

January 29th, 2024, Naogen Pharma prepares the commercial launch of a radiopharmaceutical drug “Made in Nantes”.

At the end of 2023, Naogen Pharma SAS, a Young Innovative Company (JEI) based in Nantes, obtained Marketing Authorization (MA) from the French National Agency for the Safety of Medicines…

Lire l'actualité
  • Contact
  • Legal Notice
  • Personal data
  • Exercise your rights
  • ©Kalélia
oui
Are you a healthcare professional?

By continuing on this page, you confirm that you are a healthcare professional.

Yes No